Anticancer drugs 2013
 Add to favourites!!!

Anticancer drugs


List of speakers

Latest News
Latest News: Save the dates for the III Anticancer Drugs Conference  (September 12-13, 2014. Buenos Aires, Argentina).  See  PICTURES  from the SPEAKERS that participated in the II Meeting.
Anticancer drugs

  Abstract TEMPLATE
  Download the program as  PDF



SPEAKER: Dr. Steffen Goletz, Ph.D.,  


Chief Executive and Scientific Officer



Dr. Steffen Goletz, CEO, CSO and co-founder of the biotech company GLYCOTOPE, studied biology, biochemistry and molecular biology at the universities in Heidelberg, Kaiserslautern, Manchester (UK) and Berlin and holds a Ph.D. in biochemistry. During his scientific career he worked for renowned research institutions including the Max Delbrueck Centre for Molecular Medicine (Berlin), the MRC Centre for Protein Engineering (Cambridge, UK), and the German Cancer Research Centre in Heidelberg. During his research, Dr. Goletz has focused on glycobiology, tumor immunology, antibody engineering and cellular engineering. As CSO, Steffen is responsible for the extremely successful development of GLYCOTOPEs product pipeline of glycooptimized biotherapeutics with four products currently in clinical trials. GLYCOTOPE developed the novel expression platform GlycoExpress based on human glycoengineered cell lines which is used for the generation of improved biopharmaceuticals with fully human and optimized glycosylation.


Anticancer drugs

Anticancer drugs conferences 2011 2013                                        Powered by